Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

GCLLSG 2016

The German CLL Study Group
16–18 September 2016 | Cologne, Germany

GCLLSG 2016

The German CLL Study Group
16–18 September 2016 | Cologne, Germany
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs? 2:24
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
John Gribben • 17 Sep 2016
How to overcome resistance to new compounds in CLL 2:41
How to overcome resistance to new compounds in CLL
Arnon Kater • 17 Sep 2016
Highlights from the International Workshop of the German CLL Study Group 3:11
Highlights from the International Workshop of the German CLL Study Group
Michael Hallek • 17 Sep 2016
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL 1:11
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Stephan Stilgenbauer • 17 Sep 2016
How combining an evolutionary perspective with genomic methods can advance CLL treatment 4:54
How combining an evolutionary perspective with genomic methods can advance CLL treatment
Dan Landau • 17 Sep 2016
How to treat a previously untreated CLL patient 2:51
How to treat a previously untreated CLL patient
Barbara Eichhorst • 17 Sep 2016
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting 1:25
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting
Barbara Eichhorst • 16 Sep 2016
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek 1:33
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek
Michael Hallek • 16 Sep 2016
The discovery and role of BCL2 and microRNA in CLL 4:04
The discovery and role of BCL2 and microRNA in CLL
Carlo Croce • 16 Sep 2016
Changes in research to overcome the problem of resistance to new CLL drugs 1:10
Changes in research to overcome the problem of resistance to new CLL drugs
Arnon Kater • 16 Sep 2016
The importance of the life cycle of CLL cells and how it can inform treatment 3:28
The importance of the life cycle of CLL cells and how it can inform treatment
Nicholas Chiorazzi • 16 Sep 2016
How to treat a previously treated CLL patient 2:16
How to treat a previously treated CLL patient
Carsten Niemann • 16 Sep 2016
Use of novel algorithms based on pattern recognition to identify patients in need of CLL treatment 2:31
Use of novel algorithms based on pattern recognition to identify patients in need of CLL treatment
Carsten Niemann • 16 Sep 2016
How the removal of macrophages from tissue can stop or slow down the progression of CLL 4:30
How the removal of macrophages from tissue can stop or slow down the progression of CLL
Federico Caligaris-Cappio • 16 Sep 2016
Information on the iwCLL 2017 meeting 1:06
Information on the iwCLL 2017 meeting
Stephan Stilgenbauer • 16 Sep 2016
Targeting ROR1 and a two-drug approach to cure CLL 5:30
Targeting ROR1 and a two-drug approach to cure CLL
Carlo Croce • 16 Sep 2016

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals